CIE-10

CIE-10-código E31

You are here: Inicio > CIE-10 > E00-E89 > E20-E35

- CIE-10
Clasificación Internacional de Enfermedades
- E00-E89
Enfermedades endocrinas, nutricionales y metabolicas
- E20-E35
Trastornos de otras glándulas endocrinas

E31

Disfunción poliglandular

CIE-10 Сódigo E31 para Disfunción poliglandular

Excluye: ataxia telangiectasia [Louis–Bar] (G11.3)

distrofia miotónica [Steinert] (G71.1)

seudohipoparatiroidismo (E20.)(1)

E31.0
Insuficiencia poliglandular autoinmune
E31.1
Hiperfunción poliglandular
E31.8
Otras disfunciones poliglandulares
E31.9
Disfunción poliglandular, no especificada
ICD-10
ATC
ICD-10 International Statistical Classification of Diseases and Related Health Problems 10th Revision
ICD-10

ICD-10 is the 10th revision of the International Statistical Classification of Diseases and Related Health Problems (ICD), a medical classification list by the World Health Organization (WHO).

It contains codes for diseases, signs and symptoms, abnormal findings, complaints, social circumstances, and external causes of injury or diseases.

ATC

The Anatomical Therapeutic Chemical (ATC) Classification System is used for the classification of active ingredients of drugs according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties.

It is controlled by the World Health Organization Collaborating Centre for Drug Statistics Methodology (WHOCC).

DDD

The defined daily dose (DDD) is a statistical measure of drug consumption, defined by the World Health Organization (WHO).

It is used to standardize the comparison of drug usage between different drugs or between different health care environments.

Home Contact Us